Skip to main content
N

Newomics

Newomics offers a Unified Multiomics Platform that utilizes swappable microflow and nanoflow modules for enhanced ionization in mass spectrometry, significantly improving sensitivity and throughput for proteomics, metabolomics, and single-cell omics applications. This technology addresses the limitations of conventional ion sources by providing a versatile, plug-and-play solution compatible with major mass spectrometer brands, enabling more efficient clinical diagnostics and biomarker discovery.

Berkeley, United StatesFounded 201891K+ followers
Updated 4 months ago

Funding

$7.9M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.

Funding rounds are not available yet.

Founders

Product

Problem

Conventional liquid chromatography-mass spectrometry (LC-MS) methods often suffer from limitations in sensitivity and throughput, hindering comprehensive analysis in proteomics, metabolomics, and single-cell omics. Existing ion sources may not efficiently ionize samples, leading to reduced detection of critical biomarkers and limiting the scope of clinical diagnostics and biomarker discovery.

Solution

Newomics offers the UniESI platform, a unified multiomics solution designed to enhance ionization efficiency in mass spectrometry. The platform features swappable microflow and nanoflow modules, enabling seamless adaptation to different flow rates and applications. Powered by "Multispray" technology, incorporating M3 emitters and MEA chips, the UniESI system significantly improves sensitivity, robustness, and throughput for proteomics, metabolomics, and single-cell omics. The platform's plug-and-play design ensures compatibility with mass spectrometers from major manufacturers, providing a versatile front-end solution for advanced LC-MS workflows. By enhancing ionization and reducing dead volume, Newomics' technology enables more efficient clinical diagnostics, biomarker discovery, and comprehensive multiomics analysis.

Target Audience

The primary target audience includes researchers and clinicians in proteomics, metabolomics, and single-cell omics, as well as professionals in clinical diagnostics, biomarker discovery, and drug development.

Features

  • UniESI source with swappable nanoflow and microflow modules for versatile LC-MS
  • M3 Emitters utilizing multinozzle technology to enhance ionization efficiency
  • MEA Chips monolithically integrating an LC column, an ESI emitter, and a post-column inlet
  • Plug-and-play compatibility with mass spectrometers from Thermo, Bruker, Agilent, Shimadzu, and Waters
  • Enhanced sensitivity, achieving 5-50x more sensitivity compared to conventional methods
  • High robustness with CV ≤ 5% from 300 plasma injections
  • High throughput, processing samples in under 1 minute, achieving more than 60 samples per hour
  • Inlet Pump Kit, Native MS Kit, and Flow Splitting Kit for seamless integration
This profile is AI-generated and may contain inaccuracies.